ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Cost-Effectiveness Analysis of Tisagenlecleucel, Blinatumomab, and Clofarabine for Treatment of B-cell Precursor Acute Lymphoblastic Leukemia
Mapping Intimacies
◽
10.36837/chapman.000294
◽
2021
◽
Author(s):
◽
Kamron Lotfi
Keyword(s):
Cost Effectiveness
◽
Acute Lymphoblastic Leukemia
◽
B Cell
◽
Lymphoblastic Leukemia
◽
Cost Effectiveness Analysis
◽
Cell Precursor
◽
Effectiveness Analysis
Download Full-text
Related Documents
Cited By
References
PCN142 - COST-EFFECTIVENESS ANALYSIS OF INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF ADULTS WITH RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN BULGARIA
Value in Health
◽
10.1016/j.jval.2018.09.225
◽
2018
◽
Vol 21
◽
pp. S38
Author(s):
S. Djambazov
◽
G. Slavchev
◽
M. Encheva-Malinova
◽
V. Varbanova
◽
M. Velchev
◽
...
Keyword(s):
Cost Effectiveness
◽
Acute Lymphoblastic Leukemia
◽
B Cell
◽
Lymphoblastic Leukemia
◽
Cost Effectiveness Analysis
◽
Cell Precursor
◽
Inotuzumab Ozogamicin
◽
Effectiveness Analysis
Download Full-text
Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia in Japan
Transplantation and Cellular Therapy
◽
10.1016/j.jtct.2020.12.023
◽
2020
◽
Author(s):
Shiho Wakase
◽
Takanori Teshima
◽
Jie Zhang
◽
Qiufei Ma
◽
Yoko Watanabe
◽
...
Keyword(s):
Cost Effectiveness
◽
Acute Lymphoblastic Leukemia
◽
Young Adult
◽
B Cell
◽
Lymphoblastic Leukemia
◽
Cost Effectiveness Analysis
◽
Adult Patients
◽
Effectiveness Analysis
◽
Cell Acute Lymphoblastic Leukemia
Download Full-text
PIH8 Cost-Effectiveness Analysis Of Dasatinib Versus Imatinib In Treating Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients In China
Value in Health
◽
10.1016/j.jval.2021.04.526
◽
2021
◽
Vol 24
◽
pp. S100
Author(s):
W. Cao
◽
Y. Yu
◽
L. Shi
◽
Y. Qiu
◽
H. Zhang
◽
...
Keyword(s):
Cost Effectiveness
◽
Acute Lymphoblastic Leukemia
◽
Lymphoblastic Leukemia
◽
Philadelphia Chromosome
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
◽
Philadelphia Chromosome Positive
Download Full-text
A cost effectiveness analysis of thiopurine methyltransferase testing for guiding 6-mercaptopurine dosing in children with acute lymphoblastic leukemia
Pediatric Blood & Cancer
◽
10.1002/pbc.22936
◽
2011
◽
Vol 57
(2)
◽
pp. 231-239
◽
Cited By ~ 26
Author(s):
Jennifer R. Donnan
◽
Wendy J. Ungar
◽
Maria Mathews
◽
Rebecca L. Hancock-Howard
◽
Proton Rahman
Keyword(s):
Cost Effectiveness
◽
Acute Lymphoblastic Leukemia
◽
Lymphoblastic Leukemia
◽
Cost Effectiveness Analysis
◽
Thiopurine Methyltransferase
◽
Effectiveness Analysis
Download Full-text
PCN19 COST-EFFECTIVENESS ANALYSIS OF CLOFARABINE IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA IN MEXICO
Value in Health
◽
10.1016/s1098-3015(10)75346-8
◽
2009
◽
Vol 12
(7)
◽
pp. A496
Author(s):
K Rely
◽
EG Salinas
◽
KA Pierre
◽
MEA Dorantes
Keyword(s):
Cost Effectiveness
◽
Acute Lymphoblastic Leukemia
◽
Lymphoblastic Leukemia
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
Download Full-text
What Can Cost-Effectiveness Analysis Tell Us About Chimeric Antigen Receptor T-Cell Therapy for Relapsed Acute Lymphoblastic Leukemia?
Journal of Clinical Oncology
◽
10.1200/jco.2018.79.3570
◽
2018
◽
Vol 36
(32)
◽
pp. 3183-3185
◽
Cited By ~ 3
Author(s):
Christopher R. Flowers
◽
Scott D. Ramsey
Keyword(s):
Cost Effectiveness
◽
Acute Lymphoblastic Leukemia
◽
T Cell
◽
Cell Therapy
◽
Chimeric Antigen Receptor
◽
Lymphoblastic Leukemia
◽
Antigen Receptor
◽
Cost Effectiveness Analysis
◽
T Cell Therapy
◽
Effectiveness Analysis
Download Full-text
PCN73 COST-EFFECTIVENESS OF BLINATUMOMAB VERSUS STANDARD OF CARE IN ADULT PATIENTS WITH PHILADELPHIA-CHROMOSOME-POSITIVE RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA FROM A CANADIAN HEALTHCARE SECTOR PERSPECTIVE
Value in Health
◽
10.1016/j.jval.2020.04.1575
◽
2020
◽
Vol 23
◽
pp. S36
Author(s):
T.E. Delea
◽
K. Raman
◽
D. Boyko
◽
A. Moynahan
◽
F. Dirnberger
◽
...
Keyword(s):
Cost Effectiveness
◽
Acute Lymphoblastic Leukemia
◽
B Cell
◽
Lymphoblastic Leukemia
◽
Philadelphia Chromosome
◽
Standard Of Care
◽
Adult Patients
◽
Healthcare Sector
◽
Cell Precursor
◽
Canadian Healthcare
Download Full-text
Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States
PharmacoEconomics
◽
10.1007/s40273-019-00812-6
◽
2019
◽
Vol 37
(9)
◽
pp. 1177-1193
◽
Cited By ~ 6
Author(s):
Thomas E. Delea
◽
Xinke Zhang
◽
Jordan Amdahl
◽
Diana Boyko
◽
Franziska Dirnberger
◽
...
Keyword(s):
United States
◽
Cost Effectiveness
◽
Acute Lymphoblastic Leukemia
◽
B Cell
◽
Lymphoblastic Leukemia
◽
The United States
◽
Adult Patients
◽
Cell Precursor
◽
Inotuzumab Ozogamicin
Download Full-text
A cost-effectiveness analysis of Erwinia asparaginase therapy in children with acute lymphoblastic leukemia
Pediatric Blood & Cancer
◽
10.1002/pbc.27458
◽
2018
◽
Vol 66
(1)
◽
pp. e27458
◽
Cited By ~ 4
Author(s):
Robin Q. H. Kloos
◽
Raphaële R. L. van Litsenburg
◽
Sarah Wolf
◽
Leonoor Wismans
◽
Gertjan J. L. Kaspers
◽
...
Keyword(s):
Cost Effectiveness
◽
Acute Lymphoblastic Leukemia
◽
Lymphoblastic Leukemia
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
◽
Erwinia Asparaginase
Download Full-text
Fluconazole versus mould-active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost-effectiveness analysis
International Journal of Hematology
◽
10.1007/s12185-017-2342-x
◽
2017
◽
Vol 107
(2)
◽
pp. 235-243
Author(s):
Yan Wang
◽
Yuanming Xing
◽
Lu Chen
◽
Ti Meng
◽
Ying Li
◽
...
Keyword(s):
Cost Effectiveness
◽
Acute Lymphoblastic Leukemia
◽
Clinical Outcome
◽
Lymphoblastic Leukemia
◽
Antifungal Prophylaxis
◽
Cost Effectiveness Analysis
◽
Adult Patients
◽
Effectiveness Analysis
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close